Effects of antidepressant medications on male reproduction and sexual function

Authors

abbas salmani, mohammadrafi bazrafshan,*
*Corresponding Author: Email: [email protected]

Journal of Inflammatory Diseases:Vol. 17, issue 4; 54-61
Published online:Dec 31, 2013
Article type:Review Article
How to Cite:salmani A, bazrafshan M. Effects of antidepressant medications on male reproduction and sexual function. J Inflamm Dis. 2024;17(4):e155799. doi:

Abstract

  Nowadays, with the increased prevalence of depression in the societies, researchers have focused more attention on the long term effects of antidepressant medications on reproduction and sexual function. In vitro studies have shown that tricyclic antidepressants such as imipramine and nortriptyline impair sperm motility. Also, Serotonergic antidepressants such as fluoxetine and venlafaxine reduce male reproduction indirectly via effects on sexual desire (libido), erection and ejaculatory ability. Mechanisms of antidepressants are still unknown for changes in sperm function. Only neuroendocrine factors regulating the activity of the chemical mediators may have an effective role in the male sexual function. Most of the chemical mediators affect on hypothalamic-hypophyseal-gonadal axis and influence the spermatogenesis in men by this way. They can affect sexual arousal, erection, ejaculation and orgasm by sympathetic and parasympathetic regulation control and may influence fertility by their side effects on cholinergic and adrenergic receptors. In this review, the relationship between antidepressant medications and male reproduction, effects of antidepressant medications on the male sexual function and androgens levels will be discussed.      

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

31
Jan
2018

Plasma Oxytocin Level and Sexual Dysfunction in Depressed Women Treated by Either Fluoxetine or Citalopram: a Pilot Clinical Trial

Mohammad Abbasinazari,
Mona Heidari-kord,
Azadeh Mazaheri-Meybodi,
Azadeh Eshraghi,
Nima Bayati

Abbasinazari M, Heidari-kord M, Mazaheri-Meybodi A, Eshraghi A, Bayati N. Plasma Oxytocin Level and Sexual Dysfunction in Depressed Women Treated by Either Fluoxetine or Citalopram: a Pilot Clinical Trial. Iran J Pharm Res. 2018;17(1):e124756. doi: https://doi.org/10.22037/ijpr.2018.2159

1
Jul
2013

The Role of Estrogen in the Treatment of Men with Schizophrenia

Jayashri Kulkarni,
Emmy Gavrilidis,
Roisin Worsley,
Tamsyn Van Rheenen,
Emily Hayes

Kulkarni J, Gavrilidis E, Worsley R, Van Rheenen T, Hayes E. The Role of Estrogen in the Treatment of Men with Schizophrenia. Int J Endocrinol Metab. 2013;11(3):129-136. doi: https://doi.org/10.5812/ijem.6615

7
Jul
2008

The Effects of Ecstasy on Pituitary-Gonadal Axis and Spermatogenesis in Mature Male Rats

Z Hesami,
Saeed Khatamsaz,
1 Mokhtari

Hesami Z, Khatamsaz S, Mokhtari 1. The Effects of Ecstasy on Pituitary-Gonadal Axis and Spermatogenesis in Mature Male Rats. Zahedan J Res Med Sci. 2008;10(3):e94519. doi:

30
Jan
2007

The Public Health Impact of Antidepressant Medications

Ramin Mojtabai

Mojtabai R. The Public Health Impact of Antidepressant Medications. Iran J Psychiatry Behav Sci. 2007;1(1):. doi:

30
Jun
2012

Testosterone and Aggressive Behavior in Man

Menelaos L. L. Batrinos

Batrinos ML. Testosterone and Aggressive Behavior in Man. Int J Endocrinol Metab. 2012;10(3):. doi: https://doi.org/10.5812/ijem.3661

More by these authors

abbas salmaniPubMedScholar
mohammadrafi bazrafshanPubMedScholar
Share
Cited by
Metrics